Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Wysocki

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Seminars in Nephrology|October 31, 2006
Kidney vacuolar H+ -ATPase: physiology and regulationPatricia Valles, Michael S Lapointe, Jan Wysocki, et al.
Kidney International|November 25, 2011
Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathyDaniel Batlle, Jan Wysocki, Maria J Soler, et al.
Comparative Immunology, Microbiology and Infectious Diseases|February 27, 2003
Hsp60 specific antibodies in egg yolks from laying hens naturally infected with Salmonella enterica subspecies enterica serovar EnteritidisBozena Dera-Tomaszewska, Jan Wysocki, Danuta Kunikowska, et al.
Journal of the American Society of Nephrology : JASN|July 17, 2020
Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19Jan Wysocki, Enrique Lores, Minghao Ye, et al.
Biologicals : Journal of the International Association of Biological Standardization|November 23, 2011
Structural damages in adsorbed vaccines affected by freezingWiesław Kurzątkowski, Ümit Kartoğlu, Monika Staniszewska, et al.
Journal of the American Society of Nephrology : JASN|October 6, 2006
Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetesMinghao Ye, Jan Wysocki, Josette William, et al.
Expert Opinion on Biological Therapy|October 15, 2011
Hyper-interleukin-11 novel designer molecular adjuvant targeting gp130 for whole cell cancer vaccinesWiktoria Maria Suchorska, Hanna Dams-Kozlowska, Urszula Kazimierczak, et al.
American Journal of Physiology. Renal Physiology|November 14, 2008
Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartanMaría José Soler, Minghao Ye, Jan Wysocki, et al.
Hypertension (Dallas, Tex. : 1979)|April 14, 2004
Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination?Minghao Ye, Jan Wysocki, Parveen Naaz, et al.
Scientific Reports|April 6, 2017
A Fluorometric Method of Measuring Carboxypeptidase Activities for Angiotensin II and Apelin-13Pan Liu, Jan Wysocki, Peter Serfozo, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Seminars in Nephrology|October 31, 2006
Kidney vacuolar H+ -ATPase: physiology and regulationPatricia Valles, Michael S Lapointe, Jan Wysocki, et al.
Kidney International|November 25, 2011
Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathyDaniel Batlle, Jan Wysocki, Maria J Soler, et al.
Comparative Immunology, Microbiology and Infectious Diseases|February 27, 2003
Hsp60 specific antibodies in egg yolks from laying hens naturally infected with Salmonella enterica subspecies enterica serovar EnteritidisBozena Dera-Tomaszewska, Jan Wysocki, Danuta Kunikowska, et al.
Journal of the American Society of Nephrology : JASN|July 17, 2020
Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19Jan Wysocki, Enrique Lores, Minghao Ye, et al.
Biologicals : Journal of the International Association of Biological Standardization|November 23, 2011
Structural damages in adsorbed vaccines affected by freezingWiesław Kurzątkowski, Ümit Kartoğlu, Monika Staniszewska, et al.
Journal of the American Society of Nephrology : JASN|October 6, 2006
Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetesMinghao Ye, Jan Wysocki, Josette William, et al.
Expert Opinion on Biological Therapy|October 15, 2011
Hyper-interleukin-11 novel designer molecular adjuvant targeting gp130 for whole cell cancer vaccinesWiktoria Maria Suchorska, Hanna Dams-Kozlowska, Urszula Kazimierczak, et al.
American Journal of Physiology. Renal Physiology|November 14, 2008
Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartanMaría José Soler, Minghao Ye, Jan Wysocki, et al.
Hypertension (Dallas, Tex. : 1979)|April 14, 2004
Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination?Minghao Ye, Jan Wysocki, Parveen Naaz, et al.
Scientific Reports|April 6, 2017
A Fluorometric Method of Measuring Carboxypeptidase Activities for Angiotensin II and Apelin-13Pan Liu, Jan Wysocki, Peter Serfozo, et al.
Pageof 8